31870188Luke JJ, Ascierto PA, Carlino MS, Gershenwald JE, Grob JJ, Hauschild A, Kirkwood JM, Long GV, Mohr P, Robert C, Ross M, Scolyer RA, Yoon CH, Poklepovic A, Rutkowski P, Anderson JR, Ahsan S, Ibrahim N, M Eggermont AMFuture oncology (London, England)Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Melanoma; Neoplasm Recurrence, Local; Skin NeoplasmsAdolescent; Adult; Chemotherapy, Adjuvant; Child; Clinical Trials, Phase III as Topic; Cross-Over Studies; Dermatologic Surgical Procedures; Disease-Free Survival; Female; Humans; Male; Multicenter Studies as Topic; Neoplasm Staging; Placebos; Programmed Cell Death 1 Receptor; Randomized Controlled Trials as Topic; Young AdultKEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma. Future Oncol. 2020 Jan; 16(3):4429-4438.Future Oncol2019-12-24T00:00:002019KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma.prns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAuthorshipvivo:hasSubjectAreahas subject areaInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedInformationResourcelinked information resourcerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptD000293Living Beings111389680.400538AdolescentD000328Living Beings1578255770.254432AdultD002648Living Beings93969130.440034ChildD009367Concepts & IdeasProcedures34719320.670065Neoplasm StagingD005260Physiology1992444050.191167FemaleD006801Living Beings2262862810.130052HumansAuthorship 1405670.3721590.3721591authors10.2522has subject areaD015337Concepts & IdeasProcedures971560.952363Multicenter Studies as TopicD008297Physiology1931408600.201617MaleD016032Concepts & IdeasProcedures2778500.730116Randomized Controlled Trials as TopicD008545Disorders1634540.720213MelanomaD009364Disorders33613050.61985Neoplasm Recurrence, LocalD018592Procedures1383990.901207Cross-Over StudiesD010919DevicesProcedures982180.948661PlacebosD061067Chemicals & Drugs2139290.656166Antibodies, Monoclonal, HumanizedD012878Disorders1535410.69092Skin NeoplasmsD017024Procedures1454680.865336Chemotherapy, AdjuvantD017326Activities & BehaviorsProcedures741690.934989Clinical Trials, Phase III as TopicD061026Chemicals & Drugs911590.882236Programmed Cell Death 1 ReceptorD000074322851850.820832Antineoplastic Agents, ImmunologicalD062109Procedures10160.982445Dermatologic Surgical ProceduresD018572Concepts & Ideas25812030.792696Disease-Free SurvivalD055815Living Beings97159610.423207Young Adult